Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD

References

• Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res. 2010;11:63. doi:10.1186/1465-9921-11-6320500811
   PubMed Web of Science ®Google Scholar
• Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest. 2011;139(1):165–173. doi:10.1378/chest.10-125221208876
   PubMed Web of Science ®Google Scholar
• Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem. 1998;46(12):1377–1384. doi:10.1177/0022155498046012069815279
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006;61(1):23–28. doi:10.1136/thx.2005.04220016143583
   PubMed Web of Science ®Google Scholar
• Sunyer J, Pistelli R, Plana E, et al. Systemic inflammation, genetic susceptibility and lung function. Eur Respir J. 2008;32(1):92–97. doi:10.1183/09031936.0005250718385179
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill‘ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;65(10):930–936. doi:10.1136/thx.2009.13026020627907
   PubMed Web of Science ®Google Scholar
• Vernooy JH, Kucukaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002;166(9):1218–1224. doi:10.1164/rccm.220202312403691
   PubMed Web of Science ®Google Scholar
• Paivaniemi OE, Maasilta PK, Vainikka TL, Alho HS, Karhunen PJ, Salminen US. Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis. Mediators Inflamm. 2009;2009:510254. doi:10.1155/2009/51025419503785
   PubMed Web of Science ®Google Scholar
• Ramage L, Proudfoot L, Guy K. Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles. Inhal Toxicol. 2004;16(9):607–613. doi:10.1080/0895837049046459916036753
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Calero C, Rojano B, et al. C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study. Int J Med Sci. 2013;10(8):938–947. doi:10.7150/ijms.615223801879
   PubMed Web of Science ®Google Scholar
• Calero C, Arellano E, Lopez-Villalobos JL, Sanchez-Lopez V, Moreno-Mata N, Lopez-Campos JL. Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients. BMC Pulm Med. 2014;14:95. doi:10.1186/1471-2466-14-9524884805
   PubMed Web of Science ®Google Scholar
• Emerging Risk Factors C; Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320. doi:10.1056/NEJMoa110747723034020
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251.7722560
   PubMed Web of Science ®Google Scholar
• Leon-Atance P, Moreno-Mata N, Gonzalez-Aragoneses F, et al. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification. Arch Bronconeumol. 2011;47(9):441–446. doi:10.1016/j.arbres.2011.04.00421676516
   PubMed Web of Science ®Google Scholar
• Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26(6):427–435.8817153
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.18546601
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653. doi:10.1056/NEJMoa03215815215480
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–580. doi:10.1136/thx.2003.01958815223864
   PubMed Web of Science ®Google Scholar
• Tanni SE, Pelegrino NR, Angeleli AY, Correa C, Godoy I. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond). 2010;7:29. doi:10.1186/1476-9255-7-5920534161
   PubMed Web of Science ®Google Scholar
• Agusti A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.003748322624038
   PubMed Web of Science ®Google Scholar
• de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27(5):902–907. doi:10.1183/09031936.06.0010960516455829
   PubMed Web of Science ®Google Scholar
• Ghobadi H, Fouladi N, Beukaghazadeh K, Ansarin K. Association of high sensitive CRP level and COPD assessment test scores with clinically important predictive outcomes in stable COPD patients. Tanaffos. 2015;14(1):34–41.26221150
   PubMedGoogle Scholar
• Wei J, Xiong XF, Lin YH, Zheng BX, Cheng DY. Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ. 2015;3:e1199. doi:10.7717/peerj.119926336642
   PubMed Web of Science ®Google Scholar
• Kim V, Criner GJ. The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med. 2015;21(2):133–141. doi:10.1097/MCP.000000000000014525575367
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3):634–642. doi:10.1378/chest.10-300721454400
   PubMed Web of Science ®Google Scholar
• Venugopal SK, Devaraj S, Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol. 2005;166(4):1265–1271. doi:10.1016/S0002-9440(10)62345-015793305
   PubMed Web of Science ®Google Scholar
• Lakota K, Resnik N, Mrak-Poljsak K, Sodin-Semrl S, Veranic P. Colocalization of serum amyloid a with microtubules in human coronary artery endothelial cells. J Biomed Biotechnol. 2011;2011:528276. doi:10.1155/2011/52827622131810
   PubMedGoogle Scholar
• Ji J, von Scheele I, Bergstrom J, et al. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respir Res. 2014;15:104. doi:10.1186/s12931-014-0104-325155252
   PubMed Web of Science ®Google Scholar
• Baynard T, Hilgenkamp TIM, Schroeder EC, Motl RW, Fernhall B. Measures of adiposity differentially correlate with C-reactive protein among persons with multiple sclerosis. Mult Scler Relat Disord. 2018;25:1–4. doi:10.1016/j.msard.2018.07.01030014875
   PubMed Web of Science ®Google Scholar